361 related articles for article (PubMed ID: 31485852)
1. Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease: A Meta-Analysis and Systematic Review.
Fu Y; Zhu W; Zhou Y; Chen H; Yan L; He W
Am J Cardiovasc Drugs; 2020 Apr; 20(2):139-147. PubMed ID: 31485852
[TBL] [Abstract][Full Text] [Related]
2. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Deng Y; Tong Y; Deng Y; Zou L; Li S; Chen H
J Am Heart Assoc; 2019 Jul; 8(14):e012540. PubMed ID: 31310583
[TBL] [Abstract][Full Text] [Related]
3. Real-world comparisons of reduced-dose non-vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation: a systematic review and meta-analysis.
Wang X; Fang L; Liu B; Zheng Y; Zeng J
Heart Fail Rev; 2020 Nov; 25(6):973-983. PubMed ID: 31713086
[TBL] [Abstract][Full Text] [Related]
4. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation with Coronary or Peripheral Artery Disease.
Zhang H; Xue Z; Yi D; Li X; Tan Y; Li J
Int Heart J; 2020 Mar; 61(2):231-238. PubMed ID: 32173695
[TBL] [Abstract][Full Text] [Related]
5. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Peripheral Artery Disease: a Systematic Review and Meta-Analysis.
Liao XZ; Fu YH; Ma JY; Zhu WG; Yuan P
Cardiovasc Drugs Ther; 2020 Jun; 34(3):391-399. PubMed ID: 32206988
[TBL] [Abstract][Full Text] [Related]
6. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644
[TBL] [Abstract][Full Text] [Related]
7. Effect of non-vitamin K antagonist oral anticoagulants versus warfarin in heart failure patients with atrial fibrillation.
Chen F; Zhou Y; Wan Q; Yu P; Ma J; Hu J
Heart Fail Rev; 2021 Nov; 26(6):1391-1397. PubMed ID: 32249407
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials.
Wang KL; Lopes RD; Patel MR; Büller HR; Tan DS; Chiang CE; Giugliano RP
Eur Heart J; 2019 May; 40(19):1492-1500. PubMed ID: 30590440
[TBL] [Abstract][Full Text] [Related]
9. Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis.
Grymonprez M; Vanspranghe K; Steurbaut S; De Backer TL; Lahousse L
Cardiovasc Drugs Ther; 2023 Aug; 37(4):781-791. PubMed ID: 34637052
[TBL] [Abstract][Full Text] [Related]
10. Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease.
Renda G; Ricci F; Giugliano RP; De Caterina R
J Am Coll Cardiol; 2017 Mar; 69(11):1363-1371. PubMed ID: 28302287
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the efficacy and safety of non-vitamin K antagonist oral anticoagulants with warfarin in Latin American patients with atrial fibrillation.
Su Z; Zhang H; He W; Ma J; Zeng J; Jiang X
Medicine (Baltimore); 2020 May; 99(18):e19542. PubMed ID: 32358343
[TBL] [Abstract][Full Text] [Related]
12. Appropriate doses of non-vitamin K antagonist oral anticoagulants in high-risk subgroups with atrial fibrillation: Systematic review and meta-analysis.
Kim IS; Kim HJ; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
J Cardiol; 2018 Oct; 72(4):284-291. PubMed ID: 29706404
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis.
Savarese G; Giugliano RP; Rosano GM; McMurray J; Magnani G; Filippatos G; Dellegrottaglie S; Lund LH; Trimarco B; Perrone-Filardi P
JACC Heart Fail; 2016 Nov; 4(11):870-880. PubMed ID: 27614940
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients (≥80 years of age) with atrial fibrillation: systematic review and meta-analysis.
Kang F; Su L; Fan S; Lv L; Luo B
Intern Med J; 2023 Sep; 53(9):1524-1532. PubMed ID: 37178051
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Nonvalvular Atrial Fibrillation and Cancer: A Systematic Review and Network Meta-analysis.
Barbarawi M; Barbarawi O; Corcoran J; Obeidat K; Al-Abdouh A; Mhanna M; Al Kasasbeh M; Pickett CC
Curr Probl Cardiol; 2022 Nov; 47(11):101346. PubMed ID: 35932849
[TBL] [Abstract][Full Text] [Related]
16. Non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with previous stroke or intracranial hemorrhage: A systematic review and meta-analysis of observational studies.
Guo Z; Ding X; Ye Z; Chen W; Chen Y
Clin Cardiol; 2021 Jul; 44(7):917-924. PubMed ID: 34013988
[TBL] [Abstract][Full Text] [Related]
17. Warfarin compared with non-vitamin K antagonist oral anticoagulants in subjects with liver disease and atrial fibrillation: A meta-analysis.
Su T; Fu Z; Nie Z; Guo D
Int J Clin Pract; 2021 Oct; 75(10):e14585. PubMed ID: 34192400
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of nonvitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials.
Patti G; Di Gioia G; Cavallari I; Nenna A
Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 28029216
[TBL] [Abstract][Full Text] [Related]
19. Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis.
Telles-Garcia N; Dahal K; Kocherla C; Lip GYH; Reddy P; Dominic P
Int J Cardiol; 2018 Oct; 268():143-148. PubMed ID: 30041779
[TBL] [Abstract][Full Text] [Related]
20. Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation and (Morbid) Obesity or Low Body Weight: a Systematic Review and Meta-Analysis.
Grymonprez M; De Backer TL; Steurbaut S; Boussery K; Lahousse L
Cardiovasc Drugs Ther; 2022 Aug; 36(4):749-761. PubMed ID: 33428092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
